Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

EU Debt Crisis Adds Uncertainty

The sovereign debt crisis in the EU could greatly change the landscape for contract services.
Jun 2, 2010

The sovereign debt crisis in the EU could greatly change the landscape for contract services.

EU debt crisis adds uncertainty for contract services

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments. CMOs will feel the effect of this in fewer batches and increased pressure to reduce prices.
Jun 1, 2010

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 5, 2010

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 2, 2010

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

The Lilly Way

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.
May 1, 2010

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.

Time for a Model Upgrade

CMOs' business model has all of the flaws of the captive model it is meant to replace.
Apr 7, 2010

CMOs' business model has all of the flaws of the captive model it is meant to replace.

Time for a Model Upgrade

CMOs' business model has all of the flaws of the captive model it is meant to replace.
Mar 2, 2010

CMOs' business model has all of the flaws of the captive model it is meant to replace.

A Look Ahead for 2010

Some predictions for contract services in 2010.
Feb 3, 2010

Some predictions for contract services in 2010.

Squeezed for Cash

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.
Jan 6, 2010

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here